Entry	Status	Organism	Proteomes	Organism ID	Protein names	Alternative products (isoforms)	Protein existence	Length	Mass	Natural variant	Cross-reference (dbSNP)	Modified residue	Annotation
O14746	reviewed	Homo sapiens (Human)	UP000005640: Chromosome 5	9606	Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2)	ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; IsoId=O14746-1; Sequence=Displayed; Name=2; IsoId=O14746-2; Sequence=VSP_019587, VSP_019588; Name=3; IsoId=O14746-3; Sequence=VSP_021727; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. No experimental confirmation available.; Name=4; IsoId=O14746-4; Sequence=VSP_053369, VSP_019587, VSP_019588; 	Evidence at protein level	1132	126,997	VARIANT 55 55 L -> Q (in idiopathic pulmonary fibrosis susceptibility; impaired telomerase activity; dbSNP:rs387907247). {ECO:0000269|PubMed:17392301}. /FTId=VAR_062535.; VARIANT 65 65 P -> A (associated with acute myeloid leukemia; dbSNP:rs544215765). {ECO:0000269|PubMed:19147845, ECO:0000269|PubMed:19760749}. /FTId=VAR_062780.; VARIANT 170 170 V -> M (in PFBMFT1; the mutant protein is demonstrated to cause decreased telomerase activity; dbSNP:rs387907248). {ECO:0000269|PubMed:21436073}. /FTId=VAR_068792.; VARIANT 202 202 A -> T (in PFBMFT1 and AA susceptibilty; severe and moderate; shorter telomeres; dbSNP:rs121918661). {ECO:0000269|PubMed:15814878, ECO:0000269|PubMed:15885610, ECO:0000269|PubMed:19760749}. /FTId=VAR_036863.; VARIANT 279 279 A -> T (in dbSNP:rs61748181). {ECO:0000269|PubMed:15814878}. /FTId=VAR_036864.; VARIANT 299 299 V -> M (associated with acute myeloid leukemia; dbSNP:rs756624928). {ECO:0000269|PubMed:19147845, ECO:0000269|PubMed:19760749}. /FTId=VAR_062781.; VARIANT 412 412 H -> Y (in PFBMFT1 and DKCB4; severe and moderate; associated with susceptibility to acute myelogenous leukemia; the mutant protein has 36% residual activity; dbSNP:rs34094720). {ECO:0000269|PubMed:15814878, ECO:0000269|PubMed:18042801, ECO:0000269|PubMed:19147845, ECO:0000269|PubMed:19760749, ECO:0000269|Ref.7}. /FTId=VAR_025149.; VARIANT 441 441 Missing (in AA susceptibility; associated with susceptibility to acute myeloid leukemia). {ECO:0000269|PubMed:15814878, ECO:0000269|PubMed:19147845, ECO:0000269|PubMed:19760749}. /FTId=VAR_036865.; VARIANT 522 522 R -> K (associated with acute myeloid leukemia). {ECO:0000269|PubMed:19147845, ECO:0000269|PubMed:19760749}. /FTId=VAR_062782.; VARIANT 570 570 K -> N (in AA susceptibility; abolishes telomerase catalytic activity but no effect on binding to TERC). {ECO:0000269|PubMed:16990594, ECO:0000269|PubMed:19760749}. /FTId=VAR_062536.; VARIANT 631 631 R -> Q (in AA susceptibility; dbSNP:rs199422294). {ECO:0000269|PubMed:19760749}. /FTId=VAR_062783.; VARIANT 682 682 G -> D (in AA susceptibility; non-severe; abolishes telomerase catalytic activity but little effect on binding to TERC; dbSNP:rs199422295). {ECO:0000269|PubMed:16627250, ECO:0000269|PubMed:16990594}. /FTId=VAR_062537.; VARIANT 694 694 V -> M (in PFBMFT1; moderate; dbSNP:rs121918662). {ECO:0000269|PubMed:15814878, ECO:0000269|PubMed:19760749}. /FTId=VAR_036866.; VARIANT 704 704 P -> S (in DKCB4; the mutant protein has 13% residual activity; dbSNP:rs199422297). {ECO:0000269|PubMed:18042801}. /FTId=VAR_068793.; VARIANT 716 716 A -> T (in PFBMFT1; the mutant protein is demonstrated to cause severely compromised telomerase activity; dbSNP:rs387907249). {ECO:0000269|PubMed:21436073}. /FTId=VAR_068794.; VARIANT 721 721 P -> R (in DKCB4; no effect on telomerase catalytic activity and little effect on binding to TERC; dbSNP:rs199422299). {ECO:0000269|PubMed:16332973, ECO:0000269|PubMed:16990594}. /FTId=VAR_062538.; VARIANT 726 726 T -> M (in AA susceptibility; very severe; no effect on telomerase catalytic activity but shortened telomeres; dbSNP:rs149566858). {ECO:0000269|PubMed:16627250, ECO:0000269|PubMed:16990594}. /FTId=VAR_062539.; VARIANT 772 772 Y -> C (in PFBMFT1; moderate; dbSNP:rs121918663). {ECO:0000269|PubMed:15814878}. /FTId=VAR_036867.; VARIANT 785 785 P -> L (in AA susceptibility). {ECO:0000269|PubMed:19760749}. /FTId=VAR_062784.; VARIANT 791 791 V -> I (in PFBMFT1; associated with Met-867 in cis on the same allele; the double mutant shows severe defects in telomere repeat addition processivity; dbSNP:rs141425941). {ECO:0000269|PubMed:21483807}. /FTId=VAR_068795.; VARIANT 811 811 R -> C (in DKCB4; 50% reduction in telomerase activity; dbSNP:rs199422301). {ECO:0000269|PubMed:17785587}. /FTId=VAR_062540.; VARIANT 841 841 L -> F (in PFBMFT1). {ECO:0000269|PubMed:21436073}. /FTId=VAR_068796.; VARIANT 865 865 R -> H (in PFBMFT1; dbSNP:rs121918666). {ECO:0000269|PubMed:17460043}. /FTId=VAR_036868.; VARIANT 867 867 V -> M (in PFBMFT1; associated with Ile-791 in cis on the same allele; the double mutant shows severe defects in telomere repeat addition processivity; this mutation causes most if not all of the functional defects; dbSNP:rs201159197). {ECO:0000269|PubMed:21483807}. /FTId=VAR_068797.; VARIANT 901 901 R -> W (in DKCB4; severe phenotype overlapping with Hoyeraal-Hreidarsson syndrome; very short telomeres and greatly reduced telomerase activity; dbSNP:rs199422304). {ECO:0000269|PubMed:17785587}. /FTId=VAR_062541.; VARIANT 902 902 K -> N (in DKCA2; abolishes telomerase catalytic activity but no effect on binding to TERC; dbSNP:rs121918665). {ECO:0000269|PubMed:16247010, ECO:0000269|PubMed:16990594}. /FTId=VAR_036869.; VARIANT 902 902 K -> R (in PFBMFT1; dbSNP:rs387907250). {ECO:0000269|PubMed:21436073}. /FTId=VAR_068798.; VARIANT 923 923 P -> L (in PFBMFT1; dbSNP:rs387907251). {ECO:0000269|PubMed:22512499}. /FTId=VAR_068799.; VARIANT 948 948 S -> R (in dbSNP:rs34062885). /FTId=VAR_053726.; VARIANT 979 979 R -> W (in DKCA2; shortened telomeres but no effect on telomerase catalytic activity nor on binding to TERC; dbSNP:rs199422305). {ECO:0000269|PubMed:15885610, ECO:0000269|PubMed:16990594}. /FTId=VAR_062542.; VARIANT 1025 1025 V -> F (in PFBMFT1). {ECO:0000269|PubMed:21436073}. /FTId=VAR_068800.; VARIANT 1062 1062 A -> T (increased incidence in sporadic acute myeloid leukemia; dbSNP:rs35719940). {ECO:0000269|PubMed:15814878, ECO:0000269|PubMed:19147845, ECO:0000269|PubMed:19760749, ECO:0000269|Ref.7}. /FTId=VAR_025150.; VARIANT 1090 1090 V -> M (in PFBMFT1; severe; dbSNP:rs121918664). {ECO:0000269|PubMed:15814878}. /FTId=VAR_036870.; VARIANT 1110 1110 T -> M (in idiopathic pulmonary fibrosis susceptibility; impaired telomerase activity; dbSNP:rs199422306). {ECO:0000269|PubMed:17392301}. /FTId=VAR_062543.; VARIANT 1127 1127 F -> L (in DKCA2; severe; shortened telomeres but no effect on telomerase catalytic activity nor on binding to TERC). {ECO:0000269|PubMed:15885610, ECO:0000269|PubMed:16990594}. /FTId=VAR_062544.	rs387907247 rs544215765 rs387907248 rs121918661 rs61748181 rs756624928 rs34094720 rs199422294 rs199422295 rs121918662 rs199422297 rs387907249 rs199422299 rs149566858 rs121918663 rs141425941 rs199422301 rs121918666 rs201159197 rs199422304 rs121918665 rs387907250 rs387907251 rs34062885 rs199422305 rs35719940 rs121918664 rs199422306 	MOD_RES 227 227 Phosphoserine; by PKB/AKT1. {ECO:0000269|PubMed:22366458}.; MOD_RES 457 457 Phosphoserine; by DYRK2. {ECO:0000269|PubMed:23362280}.; MOD_RES 707 707 Phosphotyrosine; by SRC-type Tyr-kinases. {ECO:0000269|PubMed:12808100, ECO:0000269|PubMed:18829466}.	5 out of 5
O70372	reviewed	Mus musculus (Mouse)	UP000000589: Chromosome 13	10090	Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit)		Evidence at protein level	1122	127,978			MOD_RES 447 447 Phosphoserine; by DYRK2. {ECO:0000250}.; MOD_RES 697 697 Phosphotyrosine; by SRC-type Tyr-kinases. {ECO:0000250}.	5 out of 5
Q673L6	reviewed	Rattus norvegicus (Rat)	UP000002494: Chromosome 1	10116	Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit)	ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1 {ECO:0000269|PubMed:16454671}; IsoId=Q673L6-1; Sequence=Displayed; Name=2 {ECO:0000269|PubMed:16454671}; Synonyms=a {ECO:0000269|PubMed:16454671}; IsoId=Q673L6-2; Sequence=VSP_052083; Name=3 {ECO:0000269|PubMed:16454671}; Synonyms=b {ECO:0000269|PubMed:16454671}, c {ECO:0000269|PubMed:16454671}; IsoId=Q673L6-3; Sequence=VSP_052081, VSP_052082; Note=Inactive form.; 	Evidence at transcript level	1125	126,934			MOD_RES 447 447 Phosphoserine; by DYRK2. {ECO:0000250}.; MOD_RES 697 697 Phosphotyrosine; by SRC-type Tyr-kinases. {ECO:0000250}.	5 out of 5
Q1PS67	reviewed	Oryzias latipes (Japanese rice fish) (Japanese killifish)	UP000001038: Unplaced	8090	Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit)	ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=A {ECO:0000303|PubMed:21547060}; Synonyms=Long {ECO:0000303|PubMed:18312429}; IsoId=Q1PS67-1; Sequence=Displayed; Name=B {ECO:0000303|PubMed:21547060}; IsoId=Q1PS67-2; Sequence=VSP_057764, VSP_057765; Name=C {ECO:0000303|PubMed:21547060}; IsoId=Q1PS67-3; Sequence=VSP_057767, VSP_057768; Name=D {ECO:0000303|PubMed:21547060}; IsoId=Q1PS67-4; Sequence=VSP_057769, VSP_057771; Name=E {ECO:0000303|PubMed:21547060}; IsoId=Q1PS67-5; Sequence=VSP_057766, VSP_057770; Name=F {ECO:0000305}; Synonyms=Short {ECO:0000303|PubMed:18312429}; IsoId=Q1PS67-6; Sequence=VSP_057772, VSP_057773; 	Evidence at protein level	1090	123,387				5 out of 5
P29590	reviewed	Homo sapiens (Human)	UP000005640: Chromosome 15	9606	Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19)	ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=12;  Name=PML-1; Synonyms=PML-I, TRIM19alpha; IsoId=P29590-1; Sequence=Displayed; Name=PML-2; Synonyms=PML-II, TRIM19kappa; IsoId=P29590-8; Sequence=VSP_040595; Name=PML-3; Synonyms=PML-III; IsoId=P29590-9; Sequence=VSP_040596, VSP_040597; Name=PML-4; Synonyms=PML-IV, PML-X, TRIM19zeta; IsoId=P29590-5; Sequence=VSP_005744, VSP_005745; Name=PML-5; Synonyms=PML-2, PML-V, TRIM19beta; IsoId=P29590-2; Sequence=VSP_005739, VSP_005740; Name=PML-6; Synonyms=PML-3B, PML-VI, TRIM19epsilon; IsoId=P29590-4; Sequence=VSP_005742, VSP_005743; Name=PML-7; Synonyms=PML-VII, TRIM19theta; IsoId=P29590-10; Sequence=VSP_040591, VSP_040594; Name=PML-8; Synonyms=PML-2G, PML-IIG, TRIM19gamma; IsoId=P29590-3; Sequence=VSP_005741; Note=Non-canonical splice sites. Might alternatively represent a polymorphic variation.; Name=PML-11; Synonyms=PML-1A, PML-IA; IsoId=P29590-11; Sequence=VSP_040590; Note=No experimental confirmation available.; Name=PML-12; Synonyms=PML-4A, PML-IVA, TRIM19lambda; IsoId=P29590-12; Sequence=VSP_040590, VSP_005744, VSP_005745; Name=PML-13; Synonyms=PML-2A, PML-IIA; IsoId=P29590-13; Sequence=VSP_040590, VSP_040595; Name=PML-14; Synonyms=PML-6B, PML-VIB, TRIM19eta, TRIM19iota; IsoId=P29590-14; Sequence=VSP_040592, VSP_040593; 	Evidence at protein level	882	97,551	VARIANT 645 645 F -> L (in dbSNP:rs5742915). {ECO:0000269|PubMed:11331580, ECO:0000269|PubMed:1720570}. /FTId=VAR_052090.	rs5742915 	MOD_RES 8 8 Phosphoserine; by HIPK2. {ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:19015637}.; MOD_RES 28 28 Phosphothreonine; by MAPK1. {ECO:0000269|PubMed:15195100}.; MOD_RES 36 36 Phosphoserine; by HIPK2 and MAPK1. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:15195100}.; MOD_RES 38 38 Phosphoserine; by HIPK2 and MAPK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:19015637}.; MOD_RES 40 40 Phosphoserine; by MAPK1. {ECO:0000269|PubMed:15195100}.; MOD_RES 42 42 Phosphothreonine. {ECO:0000269|PubMed:15195100}.; MOD_RES 48 48 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 117 117 Phosphoserine; by CHEK2. {ECO:0000269|PubMed:12402044}.; MOD_RES 403 403 Phosphoserine; by MAPK1 and MAPK7. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:22033920}.; MOD_RES 409 409 Phosphothreonine; by MAPK7. {ECO:0000269|PubMed:15195100}.; MOD_RES 487 487 N6-acetyllysine. {ECO:0000269|PubMed:18621739, ECO:0000269|PubMed:22274616}.; MOD_RES 493 493 Phosphoserine. {ECO:0000250|UniProtKB:Q60953}.; MOD_RES 504 504 Phosphoserine. {ECO:0000250|UniProtKB:Q60953}.; MOD_RES 505 505 Phosphoserine; by MAPK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:22033920}.; MOD_RES 512 512 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 515 515 N6-acetyllysine. {ECO:0000305|PubMed:18621739}.; MOD_RES 518 518 Phosphoserine; by CDK1 and CDK2. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22033920}.; MOD_RES 527 527 Phosphoserine; by MAPK1. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:22033920}.; MOD_RES 530 530 Phosphoserine; by MAPK1. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 535 535 Phosphoserine. {ECO:0000269|PubMed:15195100}.; MOD_RES 565 565 Phosphoserine; by CK2. {ECO:0000269|PubMed:22406621}.; MOD_RES 867 867 Phosphothreonine. {ECO:0000244|PubMed:23186163}.	5 out of 5
Q9SPU7	reviewed	Arabidopsis thaliana (Mouse-ear cress)	UP000006548: Chromosome 5	3702	Telomerase reverse transcriptase (AtTERT) (EC 2.7.7.49)		Evidence at protein level	1123	130,580				5 out of 5
Q6A548	reviewed	Canis lupus familiaris (Dog) (Canis familiaris)	UP000002254: Unplaced	9615	Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit)		Evidence at transcript level	1123	124,825			MOD_RES 227 227 Phosphoserine; by PKB/AKT1. {ECO:0000250}.; MOD_RES 446 446 Phosphoserine; by DYRK2. {ECO:0000250}.; MOD_RES 697 697 Phosphotyrosine; by SRC-type Tyr-kinases. {ECO:0000250}.	5 out of 5
Q27ID4	reviewed	Bos taurus (Bovine)	UP000009136: Unplaced	9913	Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit)		Inferred from homology	1125	124,447			MOD_RES 231 231 Phosphoserine; by PKB/AKT1. {ECO:0000250}.; MOD_RES 450 450 Phosphoserine; by DYRK2. {ECO:0000250}.; MOD_RES 700 700 Phosphotyrosine; by SRC-type Tyr-kinases. {ECO:0000250}.	5 out of 5
Q4KTA7	reviewed	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	UP000005226: Unplaced	31033	Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit)		Evidence at protein level	1074	122,505				5 out of 5
Q06124	reviewed	Homo sapiens (Human)	UP000005640: Chromosome 12	9606	Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3)	ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; Synonyms=PTP2Ci; IsoId=Q06124-1; Sequence=Displayed; Name=2; Synonyms=PTP2C; IsoId=Q06124-2; Sequence=VSP_016672; Name=3; IsoId=Q06124-3; Sequence=VSP_016672, VSP_016673, VSP_016674; 	Evidence at protein level	597	68,436	VARIANT 2 2 T -> I (in NS1; dbSNP:rs267606990). {ECO:0000269|PubMed:12960218}. /FTId=VAR_027183.; VARIANT 42 42 T -> A (in NS1; dbSNP:rs397507501). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12960218}. /FTId=VAR_015601.; VARIANT 58 58 N -> K (in NS1; dbSNP:rs397507506). {ECO:0000269|PubMed:12634870}. /FTId=VAR_027184.; VARIANT 59 59 T -> A (in NS1). {ECO:0000269|PubMed:19020799}. /FTId=VAR_066060.; VARIANT 60 60 G -> A (in NS1; dbSNP:rs397507509). {ECO:0000269|PubMed:11992261}. /FTId=VAR_015602.; VARIANT 60 60 G -> V (in myelodysplastic syndrome; dbSNP:rs397507509). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015990.; VARIANT 61 61 D -> G (in NS1; dbSNP:rs121918461). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12161469, ECO:0000269|PubMed:12634870}. /FTId=VAR_015603.; VARIANT 61 61 D -> N (in NS1; dbSNP:rs397507510). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12634870}. /FTId=VAR_015604.; VARIANT 61 61 D -> V (in JMML; also in myelodysplastic syndrome; dbSNP:rs121918461). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015991.; VARIANT 61 61 D -> Y (in JMML). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015992.; VARIANT 62 62 Y -> D (in NS1; also in Noonan patients manifesting juvenile myelomonocytic leukemia; dbSNP:rs121918460). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12325025, ECO:0000269|PubMed:12717436, ECO:0000269|PubMed:12960218}. /FTId=VAR_015605.; VARIANT 63 63 Y -> C (in NS1; dbSNP:rs121918459). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12161469, ECO:0000269|PubMed:12325025, ECO:0000269|PubMed:12634870, ECO:0000269|PubMed:12960218}. /FTId=VAR_015606.; VARIANT 69 69 E -> K (in JMML; also in myelodysplastic syndrome). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015993.; VARIANT 69 69 E -> Q (in NS1; dbSNP:rs397507511). {ECO:0000269|PubMed:12634870}. /FTId=VAR_027185.; VARIANT 71 71 F -> K (in acute myeloid leukemia; requires 2 nucleotide substitutions). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015994.; VARIANT 71 71 F -> L (in myelodysplastic syndrome; dbSNP:rs397507512). {ECO:0000269|PubMed:12634870, ECO:0000269|PubMed:12717436}. /FTId=VAR_015995.; VARIANT 72 72 A -> G (in NS1; dbSNP:rs121918454). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12960218}. /FTId=VAR_015607.; VARIANT 72 72 A -> S (in NS1; dbSNP:rs121918453). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:12161469, ECO:0000269|PubMed:12634870}. /FTId=VAR_015608.; VARIANT 72 72 A -> T (in JMML; dbSNP:rs121918453). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015996.; VARIANT 72 72 A -> V (in JMML; dbSNP:rs121918454). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015997.; VARIANT 73 73 T -> I (in NS1; also in Noonan patients manifesting juvenile myelomonocytic leukemia; dbSNP:rs28933387). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12161469, ECO:0000269|PubMed:12634870, ECO:0000269|PubMed:12717436}. /FTId=VAR_015609.; VARIANT 76 76 E -> A (in JMML; also in myelodysplastic syndrome; dbSNP:rs121918465). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015998.; VARIANT 76 76 E -> D (in NS1; dbSNP:rs397507514). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12634870}. /FTId=VAR_015610.; VARIANT 76 76 E -> G (in JMML; dbSNP:rs121918465). {ECO:0000269|PubMed:12717436}. /FTId=VAR_015999.; VARIANT 76 76 E -> K (in JMML; increases protein tyrosine phosphatase activity against CDC73; dbSNP:rs28933388). {ECO:0000269|PubMed:12717436, ECO:0000269|PubMed:26742426}. /FTId=VAR_016000.; VARIANT 76 76 E -> V (in JMML; dbSNP:rs121918465). {ECO:0000269|PubMed:12717436}. /FTId=VAR_016001.; VARIANT 79 79 Q -> P (in NS1). {ECO:0000269|PubMed:12960218}. /FTId=VAR_027186.; VARIANT 79 79 Q -> R (in NS1; dbSNP:rs121918466). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12529711, ECO:0000269|PubMed:12634870}. /FTId=VAR_015611.; VARIANT 106 106 D -> A (in NS1; dbSNP:rs397507517). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12960218}. /FTId=VAR_015612.; VARIANT 139 139 E -> D (in NS1; dbSNP:rs397507520). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12634870}. /FTId=VAR_015613.; VARIANT 256 256 Q -> R (in NS1; dbSNP:rs397507523). {ECO:0000269|PubMed:12634870}. /FTId=VAR_027187.; VARIANT 279 279 Y -> C (in NS1 and LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs121918456). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12058348, ECO:0000269|PubMed:12960218, ECO:0000269|PubMed:15121796, ECO:0000269|PubMed:15520399, ECO:0000269|PubMed:16679933, ECO:0000269|PubMed:26742426}. /FTId=VAR_015614.; VARIANT 279 279 Y -> S (in LPRD1; dbSNP:rs121918456). {ECO:0000269|PubMed:15121796, ECO:0000269|PubMed:15520399}. /FTId=VAR_027188.; VARIANT 282 282 I -> V (in NS1; dbSNP:rs397507529). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12634870}. /FTId=VAR_015615.; VARIANT 285 285 F -> L (in NS1; dbSNP:rs397507531). {ECO:0000269|PubMed:11992261}. /FTId=VAR_015617.; VARIANT 285 285 F -> S (in NS1; dbSNP:rs121918463). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12161469}. /FTId=VAR_015616.; VARIANT 308 308 N -> D (in NS1; common mutation; dbSNP:rs28933386). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12161469, ECO:0000269|PubMed:12634870, ECO:0000269|PubMed:12960218}. /FTId=VAR_015619.; VARIANT 308 308 N -> S (in NS1; some patients also manifest giant cell lesions of bone and soft tissue; dbSNP:rs121918455). {ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12960218}. /FTId=VAR_015618.; VARIANT 309 309 I -> V (in NS1; unknown pathological significance; dbSNP:rs201787206). {ECO:0000269|PubMed:11992261}. /FTId=VAR_015620.; VARIANT 415 415 T -> M (in NS1; dbSNP:rs121918467). {ECO:0000269|PubMed:15384080}. /FTId=VAR_027189.; VARIANT 465 465 A -> T (in LPRD1; dbSNP:rs121918468). {ECO:0000269|PubMed:15389709}. /FTId=VAR_027190.; VARIANT 468 468 G -> A (in LPRD1; dbSNP:rs121918469). {ECO:0000269|PubMed:15121796, ECO:0000269|PubMed:15389709}. /FTId=VAR_027191.; VARIANT 472 472 T -> M (in LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs121918457). {ECO:0000269|PubMed:12058348, ECO:0000269|PubMed:12960218, ECO:0000269|PubMed:15121796, ECO:0000269|PubMed:15520399, ECO:0000269|PubMed:26742426}. /FTId=VAR_015621.; VARIANT 495 495 P -> S (in NS1; increased phosphatase activity; dbSNP:rs397507539). {ECO:0000269|PubMed:24891296}. /FTId=VAR_071706.; VARIANT 502 502 R -> L (in LPRD1; dbSNP:rs397507542). {ECO:0000269|PubMed:15121796}. /FTId=VAR_027192.; VARIANT 502 502 R -> W (in LPRD1; reduced phosphatase activity; dbSNP:rs397507541). {ECO:0000269|PubMed:15121796, ECO:0000269|PubMed:24891296}. /FTId=VAR_027193.; VARIANT 505 505 R -> K (in NS1; dbSNP:rs397507543). {ECO:0000269|PubMed:11992261}. /FTId=VAR_015622.; VARIANT 506 506 S -> T (in NS1; dbSNP:rs121918458). {ECO:0000269|PubMed:12325025, ECO:0000269|PubMed:12739139}. /FTId=VAR_015623.; VARIANT 507 507 G -> A (in JMML; dbSNP:rs397507546). {ECO:0000269|PubMed:12717436}. /FTId=VAR_016002.; VARIANT 507 507 G -> R (in NS1 and JMML; JMML patient also shows growth retardation and pulmonic stenosis; dbSNP:rs397507545). {ECO:0000269|PubMed:12717436, ECO:0000269|PubMed:12960218}. /FTId=VAR_016003.; VARIANT 508 508 M -> V (in NS1; dbSNP:rs397507547). {ECO:0000269|PubMed:11704759, ECO:0000269|PubMed:11992261, ECO:0000269|PubMed:12960218}. /FTId=VAR_015624.; VARIANT 510 510 Q -> P (in LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs397509345). {ECO:0000269|PubMed:14961557, ECO:0000269|PubMed:15121796, ECO:0000269|PubMed:15690106, ECO:0000269|PubMed:26742426}. /FTId=VAR_027194.; VARIANT 510 510 Q -> R (in NS1). {ECO:0000269|PubMed:15948193}. /FTId=VAR_027195.; VARIANT 514 514 Q -> E (in NS1 and LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs397507549). {ECO:0000269|PubMed:15889278, ECO:0000269|PubMed:16733669, ECO:0000269|PubMed:26742426}. /FTId=VAR_076499.; VARIANT 514 514 Q -> P (in LPRD1; dbSNP:rs121918470). {ECO:0000269|PubMed:15520399}. /FTId=VAR_027196.; VARIANT 564 564 L -> F (in NS1; dbSNP:rs397516797). {ECO:0000269|PubMed:12960218}. /FTId=VAR_027197.	rs267606990 rs397507501 rs397507506 rs397507509 rs397507509 rs121918461 rs397507510 rs121918461 rs121918460 rs121918459 rs397507511 rs397507512 rs121918454 rs121918453 rs121918453 rs121918454 rs28933387 rs121918465 rs397507514 rs121918465 rs28933388 rs121918465 rs121918466 rs397507517 rs397507520 rs397507523 rs121918456 rs121918456 rs397507529 rs397507531 rs121918463 rs28933386 rs121918455 rs201787206 rs121918467 rs121918468 rs121918469 rs121918457 rs397507539 rs397507542 rs397507541 rs397507543 rs121918458 rs397507546 rs397507545 rs397507547 rs397509345 rs397507549 rs121918470 rs397516797 	MOD_RES 2 2 N-acetylthreonine. {ECO:0000244|PubMed:19413330}.; MOD_RES 62 62 Phosphotyrosine. {ECO:0000244|PubMed:19690332}.; MOD_RES 66 66 Phosphotyrosine. {ECO:0000250|UniProtKB:P35235}.; MOD_RES 546 546 Phosphotyrosine; by PDGFR. {ECO:0000250|UniProtKB:P35235}.; MOD_RES 584 584 Phosphotyrosine; by PDGFR. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.	5 out of 5
